Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
6.32
+0.13 (2.10%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cytek Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 162.27 | 167.3 | 296.6 | 364.62 | 165.23 | 30.12 | Upgrade
|
| Short-Term Investments | 115.51 | 95.11 | 44.55 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 277.78 | 262.41 | 341.15 | 364.62 | 165.23 | 30.12 | Upgrade
|
| Cash Growth | -3.56% | -23.08% | -6.44% | 120.67% | 448.54% | 101708.23% | Upgrade
|
| Accounts Receivable | 52.63 | 55.93 | 48.86 | 29.76 | 16.99 | 17.15 | Upgrade
|
| Other Receivables | 0.02 | 0.19 | 2.01 | -0.13 | 1.11 | 0.6 | Upgrade
|
| Receivables | 52.66 | 56.12 | 50.88 | 29.63 | 18.1 | 17.75 | Upgrade
|
| Inventory | 46.86 | 61.17 | 48.78 | 32.57 | 23.05 | 19.01 | Upgrade
|
| Prepaid Expenses | 3.15 | 3.99 | 4.45 | 4.21 | 0.91 | 0.47 | Upgrade
|
| Restricted Cash | 0.03 | 0.33 | 2.9 | - | 0.89 | 0.12 | Upgrade
|
| Other Current Assets | 9.73 | 8.04 | 5.88 | 0.71 | 0.45 | 0.3 | Upgrade
|
| Total Current Assets | 390.19 | 392.06 | 454.02 | 431.73 | 208.62 | 67.77 | Upgrade
|
| Property, Plant & Equipment | 28.63 | 29.26 | 27.57 | 5.85 | 2.14 | 1.04 | Upgrade
|
| Long-Term Investments | 1.6 | 1.6 | - | - | - | - | Upgrade
|
| Goodwill | 16.18 | 16.18 | 10.14 | 10.14 | 0.48 | 0.48 | Upgrade
|
| Other Intangible Assets | 20.49 | 23.08 | 4.33 | 4.74 | 0.27 | 0.26 | Upgrade
|
| Long-Term Deferred Tax Assets | 30.78 | 30.49 | 20.46 | 9.17 | 7.38 | - | Upgrade
|
| Other Long-Term Assets | 3.35 | 1.79 | 2.96 | 1.67 | 1.09 | 0.82 | Upgrade
|
| Total Assets | 491.23 | 494.46 | 519.48 | 463.31 | 219.98 | 70.36 | Upgrade
|
| Accounts Payable | 5.39 | 3.03 | 4.81 | 3.03 | 2.94 | 2.34 | Upgrade
|
| Accrued Expenses | 20.12 | 18.99 | 20.42 | 14.89 | 8.65 | 6.17 | Upgrade
|
| Short-Term Debt | - | - | - | - | 2.77 | - | Upgrade
|
| Current Portion of Long-Term Debt | 2 | 0.57 | 0.58 | - | - | - | Upgrade
|
| Current Portion of Leases | 3.53 | 2.44 | 2.93 | - | - | - | Upgrade
|
| Current Income Taxes Payable | 0.4 | 1.3 | 0.25 | 2.48 | 0.47 | 0.31 | Upgrade
|
| Current Unearned Revenue | 26.71 | 24.13 | 14.54 | 8.1 | 4.29 | 3.47 | Upgrade
|
| Other Current Liabilities | 4.66 | 5.76 | 5.52 | 4.68 | 7.42 | 8.75 | Upgrade
|
| Total Current Liabilities | 62.8 | 56.23 | 49.04 | 33.18 | 26.54 | 21.04 | Upgrade
|
| Long-Term Debt | 1.24 | 1.65 | 2.27 | - | - | - | Upgrade
|
| Long-Term Leases | 7.76 | 9.48 | 12.31 | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | 14.79 | 15.13 | 13.12 | 9.79 | 3.46 | 1.78 | Upgrade
|
| Other Long-Term Liabilities | 19.19 | 18.91 | 17.18 | 14.95 | 11.7 | 14.59 | Upgrade
|
| Total Liabilities | 105.76 | 101.39 | 93.93 | 57.92 | 41.69 | 37.41 | Upgrade
|
| Common Stock | 0.13 | 0.13 | 0.14 | 0.13 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 430.07 | 423.39 | 442.89 | 423.63 | 6.49 | 0.44 | Upgrade
|
| Retained Earnings | -44.84 | -29.18 | -17.03 | -19.61 | -22.61 | -42.02 | Upgrade
|
| Comprehensive Income & Other | 0.1 | -1.28 | -0.7 | 0.9 | 0.07 | -0.15 | Upgrade
|
| Total Common Equity | 385.46 | 393.06 | 425.3 | 405.04 | -16.03 | -41.7 | Upgrade
|
| Minority Interest | - | - | 0.25 | 0.34 | - | - | Upgrade
|
| Shareholders' Equity | 385.46 | 393.06 | 425.55 | 405.39 | 178.29 | 32.95 | Upgrade
|
| Total Liabilities & Equity | 491.23 | 494.46 | 519.48 | 463.31 | 219.98 | 70.36 | Upgrade
|
| Total Debt | 14.52 | 14.14 | 18.09 | - | 2.77 | - | Upgrade
|
| Net Cash (Debt) | 263.26 | 248.27 | 323.06 | 364.62 | 162.46 | 30.12 | Upgrade
|
| Net Cash Growth | -3.47% | -23.15% | -11.40% | 124.44% | 439.34% | - | Upgrade
|
| Net Cash Per Share | 2.00 | 1.84 | 2.33 | 4.47 | 4.98 | 1.08 | Upgrade
|
| Filing Date Shares Outstanding | 128.81 | 130.82 | 135.43 | 134.08 | 31.24 | 27.93 | Upgrade
|
| Total Common Shares Outstanding | 129.77 | 130.71 | 135.37 | 133.75 | 31.24 | 27.93 | Upgrade
|
| Working Capital | 327.39 | 335.83 | 404.98 | 398.55 | 182.09 | 46.73 | Upgrade
|
| Book Value Per Share | 2.97 | 3.01 | 3.14 | 3.03 | -0.51 | -1.49 | Upgrade
|
| Tangible Book Value | 348.79 | 353.8 | 410.82 | 390.16 | -16.78 | -42.44 | Upgrade
|
| Tangible Book Value Per Share | 2.69 | 2.71 | 3.03 | 2.92 | -0.54 | -1.52 | Upgrade
|
| Buildings | 8.08 | 7.65 | 5.55 | - | - | - | Upgrade
|
| Machinery | 15.07 | 12.79 | 7.63 | 4.35 | 1.97 | 0.68 | Upgrade
|
| Construction In Progress | 0.21 | 0.26 | 0.18 | 0.34 | - | - | Upgrade
|
| Leasehold Improvements | 3.17 | 3.62 | 3.48 | 3.02 | 1.11 | 0.76 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.